(Q80810673)

English

New drugs for asthma

scientific article published on 01 October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

New drugs for asthma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

author name string

Peter J Barnes

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 October 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

831-844

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1038/nrd1524

0 references

The health economics of asthma and rhinitis. I. Assessing the economic impact

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Early thickening of the reticular basement membrane in children with difficult asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

How do corticosteroids work in asthma?

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Anti-leukotrienes: here to stay?

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Functional characteristics of cysteinyl-leukotriene receptor subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Prostaglandin D2 as a mediator of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Endothelin antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Exhaled markers of pulmonary disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of theophylline and adenosine on eosinophil function

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

ATP modulates anti-IgE-induced release of histamine from human lung mast cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Synthesis of potent and highly selective inhibitors of human tryptase

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Inhibitory cytokines in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Endogenous inhibitory mechanisms in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Cytokine traps: multi-component, high-affinity blockers of cytokine action

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

An immune cell-selective interleukin 4 agonist

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

IL-4/IL-13 signaling beyond JAK/STAT

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

STAT6: an intracellular target for the inhibition of allergic disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-13 in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Critical role for IL-13 in the development of allergen-induced airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-13: central mediator of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-1 receptor antagonist: role in biology

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Biologic activities of IL-1 and its role in human disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The potential role of tumour necrosis factor alpha in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Anti-TNF-alpha therapies: the next generation

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

IL-10: a key regulator of allergic disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The effects of nebulized recombinant interferon-gamma in asthmatic airways

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The biology of chemokines and their receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Chemokine receptors: multifaceted therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Cyclic nucleotide phosphodiesterases

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Cilomilast: a breath of relief?

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Kinase regulation in inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Differential IκB Kinase Activation and IκBα Degradation by Interleukin-1β and Tumor Necrosis Factor-α in Human U937 Monocytic Cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The function role of GATA-3 in Th1 and Th2 differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Contribution of intercellular-adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitised brown-Norway rats.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Regulatory mechanisms of eosinophil adhesion to and transmigration across endothelial cells by alpha4 and beta2 integrins

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Natalizumab for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Antagonism of selectin-dependent adhesion of human eosinophils and neutrophils by glycomimetics and oligosaccharide compounds

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Inhibition of volume-activated chloride currents in endothelial cells by chromones

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

The role of co-stimulation in airway inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Costimulation of T cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

DNA-based immunotherapeutics for the treatment of allergic disease.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Treatment of established asthma in a murine model using CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Medicinal chemistry and therapeutic potential of CpG DNA.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Asthma genetics

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Pharmacogenetics of asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

ADAM33: a novel therapeutic target for asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

DNA antisense therapy for asthma in an animal model

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Discovery and development of respirable antisense therapeutics for asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Small RNA: can RNA interference be exploited for therapy?

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

31 March 2020

Anti-IgE for chronic asthma

1 reference

https://api.crossref.org/works/10.1038%2FNRD1524

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinase inhibitors and airway inflammation.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.EJPHAR.2005.12.054

Identifiers

10.1038/NRD1524

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15459674%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80810673&oldid=2052808546"